http://www.thehindu.com/news/cities/Hyderabad/Neurodegenerative-diseases/article13983720.ece

Suven Life Sciences Ltd has got a product patent each from Canada, African Regional Intellectual Property Organisation (ARIPO) and South Korea for new chemical entities used in the treatment of disorders associated with neurodegenerative diseases. These patents are valid through 2030.The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven. They are being developed as therapeutic agents and useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia, the company said on Tuesday.